Momentum

Agreement Cloud for Life Sciences: Business Continuity and Compliance

COVID-19 has altered life sciences. Hear from Boehringer Ingelheim on how they digitized their legal and manufacturing processes in response to COVID-19. See newly released and upcoming product enhancements that improves the ability to attain internal and external signatures that are compliant with the FDA’s 21 CFR Part 11 regulations.

Register for Webinar